Symrise sells AmeriTerpenes to Mutares
Analysis based on 8 articles · First reported Sep 01, 2026 · Last updated Sep 02, 2026
The divestiture is expected to result in a mid-double-digit million-euro non-cash disposal loss for Symrise, which may weigh on its 2026 earnings but aligns with its portfolio optimization strategy. For Mutares SE & Co. KGaA, the acquisition represents a strategic expansion in the U.S. chemicals market, potentially enhancing its growth prospects.
On September 1, 2026, Symrise AG announced the signing and simultaneous closing of a definitive agreement to sell AmeriTerpenes LLC, its terpene ingredients business, to Mutares SE & Co. KGaA SE & Co. KGaA. The transaction, with undisclosed financial terms, is part of Symrise's ONE Symrise strategy to sharpen its portfolio and focus on core growth platforms. AmeriTerpenes, a producer of renewable terpene ingredients with manufacturing sites in Jacksonville, Florida and Colonels Island, Georgia, will become a new platform investment for Mutares SE & Co. KGaA' Chemicals & Materials segment, strengthening its U.S. footprint. Symrise expects a non-cash disposal loss in the mid-double-digit million-euro range, to be reflected in its 2026 annual financial statements. Symrise and AmeriTerpenes will continue their commercial relationship through supply arrangements. Symrise was advised by Stifel, Alvarez and Marsal, and Troutman Pepper Locke LLP. Symrise shares closed at €92.20 on Monday, down 0.75% on XETRA.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard